Literature DB >> 11212460

Genetic polymorphism and outcomes with azathioprine and 6-mercaptopurine.

S J Gardiner, E J Begg, M L Barclay, C M Kirkpatrick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11212460

Source DB:  PubMed          Journal:  Adverse Drug React Toxicol Rev        ISSN: 0964-198X


× No keyword cloud information.
  6 in total

Review 1.  Part 1: background, methodology, and clinical adoption of pharmacogenetics.

Authors:  Maarten J Deenen; Annemieke Cats; Jos H Beijnen; Jan H M Schellens
Journal:  Oncologist       Date:  2011-05-31

2.  Pharmacoeconomic analyses of azathioprine, methotrexate and prospective pharmacogenetic testing for the management of inflammatory bowel disease.

Authors:  Virginia L Priest; Evan J Begg; Sharon J Gardiner; Christopher M A Frampton; Richard B Gearry; Murray L Barclay; David W J Clark; Paul Hansen
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 3.  Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.

Authors:  Tessa M Bosch; Irma Meijerman; Jos H Beijnen; Jan H M Schellens
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 4.  Part 3: Pharmacogenetic variability in phase II anticancer drug metabolism.

Authors:  Maarten J Deenen; Annemieke Cats; Jos H Beijnen; Jan H M Schellens
Journal:  Oncologist       Date:  2011-06-09

5.  TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients.

Authors:  Mateusz Kurzawski; Krzysztof Dziewanowski; Agnieszka Lener; Marek Drozdzik
Journal:  Eur J Clin Pharmacol       Date:  2009-02-20       Impact factor: 2.953

6.  Association between thiopurine S-methyltransferase polymorphisms and thiopurine-induced adverse drug reactions in patients with inflammatory bowel disease: a meta-analysis.

Authors:  Yue-Ping Liu; Hai-Yan Wu; Xiang Yang; Han-Qing Xu; Yong-Chuan Li; Da-Chuan Shi; Jun-Fu Huang; Qing Huang; Wei-Ling Fu
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.